000 01322cam  2200349zi 4500
0019.873424
003CaOODSP
00520221107163918
006m     o  d f      
007cr |||||||||||
008190522t20192019onc    #o    f000 0 eng d
020 |a9780660310107
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-277/2019E-PDF
24500|aGuidance document : |bmanagement of drug submissions and applications.
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2019.
264 4|c©2019
300 |a1 online resource (61 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Ligne directrice : gestion des présentations de drogues et demandes.
500 |aCover title.
500 |a"Date adopted: January 2018. Revised date: 2019/02/15. Effective date: 2019/07/25."
69207|2gccst|aDrugs
69207|2gccst|aSubmissions
7101 |aCanada. |bHealth Canada.
77508|tLigne directrice : |w(CaOODSP)9.873425
794 |tGuidance document : |w(CaOODSP)9.896428
795 |tGuidance for industry : |w(CaOODSP)9.688015
85640|qPDF|s827 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H164-277-2019-eng.pdf